Pentabromopseudilin: a myosin V inhibitor suppresses TGF-β activity by recruiting the type II TGF-β receptor to lysosomal degradation

References

• Burkholder PR, Pfister RM, Leitz FH. Production of a pyrrole antibiotic by a marine bacterium. Appl Microbiol 1966;14:649–53.
   PubMedGoogle Scholar
• Ohri RV, Radosevich AT, Hrovat KJ, et al. A Re(V)-catalyzed C-N bond-forming route to human lipoxygenase inhibitors. Org Lett 2005;7:2501–4.
   PubMed Web of Science ®Google Scholar
• Preller M, Chinthalapudi K, Martin R, et al. Inhibition of Myosin ATPase activity by halogenated pseudilins: a structure-activity study. J Med Chem 2011;54:3675–85.
   PubMed Web of Science ®Google Scholar
• Martin R, Jäger A, Böhl M, et al. Total synthesis of pentabromo- and pentachloropseudilin, and synthetic analogues–allosteric inhibitors of myosin ATPase. Angew Chem Int Ed Engl 2009;48:8042–6.
   PubMed Web of Science ®Google Scholar
• Fedorov R, Böhl M, Tsiavaliaris G, et al. The mechanism of pentabromopseudilin inhibition of myosin motor activity. Nat Struct Mol Biol 2009;16:80–8.
   PubMed Web of Science ®Google Scholar
• Miaczynska M, Pelkmans L, Zerial M. Not just a sink: endosomes in control of signal transduction. Curr Opin Cell Biol 2004;16:400–6.
   PubMed Web of Science ®Google Scholar
• Hanyaloglu AC, von Zastrow M. Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 2008;48:537–68.
   PubMed Web of Science ®Google Scholar
• Scita G, Di Fiore PP. The endocytic matrix. Nature 2010;463:464–73.
   PubMed Web of Science ®Google Scholar
• Hu Y, Chuang JZ, Xu K, et al. SARA, a FYVE domain protein, affects Rab5-mediated endocytosis. J Cell Sci 2002;115:4755–63.
   PubMed Web of Science ®Google Scholar
• Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 2003;5:410–21.
   PubMed Web of Science ®Google Scholar
• Mitchell H, Choudhury A, Pagano RE, Leof EB. Ligand-dependent and -independent transforming growth factor-beta receptor recycling regulated by clathrin-mediated endocytosis and Rab11. Mol Biol Cell 2004;15:4166–78.
   PubMed Web of Science ®Google Scholar
• Chen CL, Hou WH, Liu IH, et al. Inhibitors of clathrin-dependent endocytosis enhance TGFbeta signaling and responses. J Cell Sci 2009;122:1863–71.
   PubMed Web of Science ®Google Scholar
• Huang SS, Liu IH, Chen CL, et al. 7-Dehydrocholesterol (7-DHC), but not cholesterol, causes suppression of canonical TGF-beta signaling and is likely involved in the development of atherosclerotic cardiovascular disease (ASCVD). J Cell Biochem 2017;118:1387–400.
   PubMed Web of Science ®Google Scholar
• Chen CL, Tetri LH, Neuschwander-Tetri BA, et al. A mechanism by which dietary trans fats cause atherosclerosis. J Nutr Biochem 2011;22:649–55.
   PubMed Web of Science ®Google Scholar
• Chen CL, Chen YP, Lin MW, et al. Euphol from Euphorbia tirucalli negatively modulates TGF-beta responsiveness via TGF-beta receptor segregation inside membrane rafts. PLoS One 2015;10:e0140249.
   PubMed Web of Science ®Google Scholar
• Martin R, Risacher C, Barthel A, et al. Silver(I)-catalyzed route to pyrroles: synthesis of halogenated pseudilins as allosteric inhibitors for myosin ATPase and X-ray crystal structures of the protein-inhibitor complexes. Eur J Org Chem 2014;21:4487–505.
   Web of Science ®Google Scholar
• Huang SS, Chen CL, Huang FW, et al. DMSO enhances TGF-β activity by recruiting the type II TGF-β receptor from intracellular vesicles to the plasma membrane. J Cell Biochem 2016;117:1568–79.
   PubMed Web of Science ®Google Scholar
• Poncelet AC, de Caestecker MP, Schnaper HW. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int 1999;56:1354–65.
   PubMed Web of Science ®Google Scholar
• Cobbs SL, Gooch JL. NFATc is required for TGFbeta-mediated transcriptional regulation of fibronectin. Biochem Biophys Res Commun 2007;362:288–94.
   PubMed Web of Science ®Google Scholar
• Widom RL, Culic I, Lee JY, Korn JH. Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. Gene 1997;198:407–20.
   PubMed Web of Science ®Google Scholar
• Chen CL, Yang PH, Kao YC, et al. Pentabromophenol suppresses TGF-beta signaling by accelerating degradation of type II TGF-beta receptors via caveolae-mediated endocytosis. Sci Rep 2017;7:43206.
   PubMed Web of Science ®Google Scholar
• Chen CL, Kao YC, Yang PH, et al. A small dibromotyrosine derivative purified from Pseudoceratina Sp. suppresses TGF-β responsiveness by inhibiting TGF-β type I receptor serine/threonine kinase activity. J Cell Biochem 2016;117:2800–14.
   PubMed Web of Science ®Google Scholar
• Chen CL, Liu IH, Fliesler SJ, et al. Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis. J Cell Sci 2007;120:3509–21.
   PubMed Web of Science ®Google Scholar
• Zhao B, Wang Q, Du J, et al. PICK1 promotes caveolin-dependent degradation of TGF-β type I receptor. Cell Res 2012;22:1467–78.
   PubMed Web of Science ®Google Scholar
• Ozdamar B, Bose R, Barrios-Rodiles M, et al. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005;307:1603–9.
   PubMed Web of Science ®Google Scholar
• Lecuona E, Minin A, Trejo HE, et al. Myosin-Va restrains the trafficking of Na+/K+-ATPase-containing vesicles in alveolar epithelial cells. J Cell Sci 2009;122:3915–22.
   PubMed Web of Science ®Google Scholar
• Le Roy C, Wrana JL. Clathrin- and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 2005;6:112–26.
   PubMed Web of Science ®Google Scholar
• Chen YG. Endocytic regulation of TGF-beta signaling. Cell Res 2009;19:58–70.
   PubMed Web of Science ®Google Scholar
• Lonn P, Moren A, Raja E, et al. Regulating the stability of TGF beta receptors and Smads. Cell Res 2009;19:21–35.
   PubMed Web of Science ®Google Scholar
• Chung CL, Wang SW, Martin R, et al. Pentachloropseudilin inhibits transforming growth factor-beta (TGF-beta) activity by accelerating cell-surface type II TGF-beta receptor turnover in target cells. ChemBioChem 2018;19:851–64.
   PubMed Web of Science ®Google Scholar
• Willems E, Cabral-Teixeira J, Schade D, et al. Small molecule-mediated TGF-beta type II receptor degradation promotes cardiomyogenesis in embryonic stem cells. Cell Stem Cell 2012;11:242–52.
   PubMed Web of Science ®Google Scholar
• Razani B, Zhang XL, Bitzer M, et al. Caveolin-1 regulates transforming growth factor (TGF)-beta/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem 2001;276:6727–38.
   PubMed Web of Science ®Google Scholar
• Penheiter SG, Mitchell H, Garamszegi N, et al. Internalization-dependent and -independent requirements for transforming growth factor beta receptor signaling via the Smad pathway. Mol Cell Biol 2002;22:4750–9.
   PubMed Web of Science ®Google Scholar
• Hayes S, Chawla A, Corvera S. TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 2002;158:1239–49.
   PubMed Web of Science ®Google Scholar
• Bond LM, Tumbarello DA, Kendrick-Jones J, Buss F. Small-molecule inhibitors of myosin proteins. Future Med Chem 2013;5:41–52.
   PubMed Web of Science ®Google Scholar
• Sellers JR, Veigel C. Walking with myosin V. Curr Opin Cell Biol 2006;18:68–73.
   PubMed Web of Science ®Google Scholar
• Vale RD. Myosin V motor proteins: marching stepwise towards a mechanism. J Cell Biol 2003;163:445–50.
   PubMed Web of Science ®Google Scholar
• Rudolf R, Bittins CM, Gerdes HH. The role of myosin V in exocytosis and synaptic plasticity. J Neurochem 2011;116:177–91.
   PubMed Web of Science ®Google Scholar
• Bond LM, Brandstaetter H, Sellers JR, et al. Myosin motor proteins are involved in the final stages of the secretory pathways. Biochem Soc Trans 2011;39:1115–19.
   PubMed Web of Science ®Google Scholar